Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
22.39
-0.71 (-3.05%)
Mar 31, 2025, 9:44 AM EDT - Market open
KNSA Revenue
In the year 2024, Kiniksa Pharmaceuticals International, had annual revenue of $423.24M with 56.60% growth. Kiniksa Pharmaceuticals International, had revenue of $122.54M in the quarter ending December 31, 2024, with 46.93% growth.
Revenue (ttm)
$423.24M
Revenue Growth
+56.60%
P/S Ratio
3.90
Revenue / Employee
$1,343,616
Employees
315
Market Cap
1.63B
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
KNSA News
- 4 weeks ago - Big Pipeline Updates From Kiniksa Pharmaceuticals - Seeking Alpha
- 4 weeks ago - Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Portfolio Execution - GlobeNewsWire
- 4 weeks ago - Kiniksa Pharmaceuticals Announces Development of KPL-387 in Recurrent Pericarditis and Updates Corporate Strategy - GlobeNewsWire
- 5 weeks ago - Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025 - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance - GlobeNewsWire
- 2 months ago - Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 4 months ago - Kiniksa Pharmaceuticals to Present at 7th Annual Evercore ISI HealthCONx Conference - GlobeNewsWire